The nutraceutical sector has been on prime focus among many investors in recent times and there are now a large number of listed companies to choose from if one chooses to make an investment in that sector. One of the companies from the nutraceutical sector that could be tracked by investors at this point in time is Stemtech Corporation (OTCMKTS:STEK).
On Thursday, STEK stock ended flat at $3 with more than 2 shares, compared to a volume of 388 shares. The stock moved within a range of $3.0000 – 3.0000 after opening trade at $3.
About Stemtech Corporation (OTCMKTS:STEK)
The stock had been trading in a range on Thursday but that does not mean that it ought to be ignored. It remains a company that has done significant work in this particular sector since it had been founded in 2018 and it may be a good time for investors to look into its business a bit more closely. The company had been founded after the acquisition of the preceding company Stemtech International in 2018.
It should also be noted that from 2010 through 2015, Stemtech International Inc had been lauded as one of the 5000 fastest-growing firms. However, in 2018, the company conducted a massive reorganization of its executive team and then commenced operations as Stemtech Corporation.
Stemtech Corporation Announces Ana Groenewold Achieves Chairman’s Club Director Status
Although the stock was trading within a range on Thursday, it should be noted that the company was in the news yesterday and it is something that investors could look into. The company announced yesterday that one of its independent business partners, Ana Groenewold, who is based out of Mexico, had managed to get the rank of Chairman’s Club Director last month.
The appointment to that role was also at the same when the 90-day promotion period for GLD RSH had been going on. During the course of that period, the recruitment and sales had hit a record for the month of May.
“Ana is a very dedicated and determined person who set her sights on becoming a Chairman’s Club Director and excitedly attained this high rank in May,” says John W. Meyer, President & COO of Stemtech Corporation. “Stemtech is proud of Ana’s accomplishments and applauds her efforts to share the benefits of our great products and business opportunity” continued Meyer. “Chairman & CEO Charles Arnold and I both were very happy to call Ana and congratulate her on success”, said Meyer. Ana Groenewold has worked with so many, including Stemtech’s Managing Director of Latin Markets, Alejandro Carrillo, who expresses his admiration for Ana’s drive to succeed.
Stemtech Corporation Uplists To OTCQB
Last month there was another major development that may have come as a boost for Stemtech as well. On May 18 the company announced that it had been awarded the coveted approval for an uplisting on to the OTCQB Venture Market. It was a major new development for the company since it will expose the company’s stock to a bigger pool of investors.